Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.002
Sell
RSI(14)
41.995
Neutral
STOCH(KDJ)(9,3,3)
18.870
Sell
ATR(14)
0.004
High Vlolatility
CCI(14)
-116.667
Sell
Williams %R
100.000
Oversold
TRIX(12,20)
-1.755
Sell
StochRSI(14)
19.536
Sell
Cardio Diagnostics Holdings Inc
CDIOWView Detailed Chart
0.015USD
0.0000.00%
Close 08/01, 16:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-1.36%
5 Days
+Infinity%
1 Month
+Infinity%
6 Months
-75.75%
Year to Date
-82.51%
1 Year
-67.78%
View Detailed Chart
Agency Rating
No Data
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Sell
Moving Average
Indicators
Value
Direction
MA5
0.006
Buy
MA10
0.009
Buy
MA20
0.010
Buy
MA50
0.013
Buy
MA100
0.019
Sell
MA200
0.037
Sell
News
More news coming soon, stay tuned...
Financial Indicators
EPS
No Data
Total revenue
No Data
Company
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Ticker SymbolCDIOW
CompanyCardio Diagnostics Holdings Inc
CEODr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Website
Related Instruments
+0.09%
-13.67%
+0.52%
-1.87%
-0.70%
-0.15%
+2.65%
+1.31%
-1.63%
-0.96%
+1.14%
+0.56%
+2.87%
-3.00%
+1.73%
-2.76%
+0.29%
+0.14%
-1.60%
-0.69%
